Chinese biotech Hutchmed today announces that the New Drug Application (NDA) for fanregratinib (HMPL-453) for the treatment of adult patients with advanced, metastatic or unresectable intrahepatic ...
As many people consider lifestyle changes at the start of the year, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is urging the public to make sure any weight-loss medicines they ...
Against the backdrop of a turbulent year marked by both breakthrough and setbacks, the biopharmaceutical industry is entering ...
The share of imported drugs in the Russian pharmaceutical market should significantly decline over the next six years, while ...
A privately held biopharmaceutical company based in the United States. Its development and planned commercialization ...
By Emma Banks, chief executive at ramarketing If I had to describe 2025 in one phrase, it would be this: a year of two halves ...
Seattle, USA-based biotech Omeros Corp saw its shares leap 75.5% to $15.36 by close of trading Wednesday, as it revealed that ...
M&A news last week featured French pharma major Sanofi announcing an agreement to acquire US vaccine maker Dynavax ...
39-43 Putney High Street, Putney London, SW15 1SP United Kingdom ...
Neok Biotech’s $75 million series A venture round, which took the California-based biotech out of stealth mode, was not the ...
US rare disease specialist Agios Pharmaceuticals (Nasdaq: AGIO) has won approval for Aqvesme (mitapivat) to treat anemia in adults with alpha- or beta-thalassaemia, covering both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback